GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Days Sales Outstanding

A (Agilent Technologies) Days Sales Outstanding : 68.42 (As of Oct. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Days Sales Outstanding?

Agilent Technologies's average Accounts Receivable for the three months ended in Oct. 2024 was $1,276 Mil. Agilent Technologies's Revenue for the three months ended in Oct. 2024 was $1,701 Mil. Hence, Agilent Technologies's Days Sales Outstanding for the three months ended in Oct. 2024 was 68.42.

The historical rank and industry rank for Agilent Technologies's Days Sales Outstanding or its related term are showing as below:

A' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.73   Med: 62.07   Max: 73.31
Current: 71.61

During the past 13 years, Agilent Technologies's highest Days Sales Outstanding was 73.31. The lowest was 53.73. And the median was 62.07.

A's Days Sales Outstanding is ranked worse than
57.75% of 213 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.69 vs A: 71.61

Agilent Technologies's Days Sales Outstanding declined from Oct. 2023 (71.09) to Oct. 2024 (68.42).


Agilent Technologies Days Sales Outstanding Historical Data

The historical data trend for Agilent Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Days Sales Outstanding Chart

Agilent Technologies Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.27 63.83 68.68 72.01 73.31

Agilent Technologies Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.09 71.16 73.79 71.59 68.42

Competitive Comparison of Agilent Technologies's Days Sales Outstanding

For the Diagnostics & Research subindustry, Agilent Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Days Sales Outstanding falls into.



Agilent Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Agilent Technologies's Days Sales Outstanding for the fiscal year that ended in Oct. 2024 is calculated as

Days Sales Outstanding (A: Oct. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2023 ) + Accounts Receivable (A: Oct. 2024 )) / count ) / Revenue (A: Oct. 2024 )*Days in Period
=( (1291 + 1324) / 2 ) / 6510*365
=1307.5 / 6510*365
=73.31

Agilent Technologies's Days Sales Outstanding for the quarter that ended in Oct. 2024 is calculated as:

Days Sales Outstanding (Q: Oct. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2024 ) + Accounts Receivable (A: Oct. 2024 )) / count ) / Revenue (A: Oct. 2024 )*Days in Period
=( (1227 + 1324) / 2 ) / 1701*365 / 4
=1275.5 / 1701*365 / 4
=68.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilent Technologies  (NYSE:A) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Agilent Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilent Technologies Business Description

Address
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Executives
Padraig Mcdonnell officer: Senior Vice President 5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051
Dominique Grau officer: Senior Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Philip Binns officer: Senior Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen officer: CEO and President 5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
Rodney Gonsalves officer: V.P., Corporate Controller 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Heidi Fields director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Henrik Ancher-jensen officer: Sr. Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
George A Scangos director C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley director 5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten director 5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand director C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Sue H. Rataj director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Dow R Wilson director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh director C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Hans Edgar Bishop director 60 WEST 66TH STREET, 26A, NEW YORK NY 10023